February 2017 - Volume 23 - Supplement 1
pp: S1-S120

PDF Only


O-002 Predicting a Complicated Course for Children Newly Diagnosed with Crohn's Disease: A Multicenter Inception Cohort Study.

Kugathasan, Subra; Denson, Lee; Walters, Thomas; More

Inflammatory Bowel Diseases . 23():S1, February 2017.


PDF Only



PDF Only


O-009 Long ncRNA Landscape in the Ileum of Treatment Naive Early Onset Crohn Disease.

Haberman, Yael; Ben-Shoshan, Marina; Di-Segni, Ayelet; More

Inflammatory Bowel Diseases . 23():S3-S4, February 2017.

O-011 Low-dose IL-2 Administration Expands Human Regulatory T Cells in Patients with UC and Humanized Mice and Protects Against Experimental Colitis.

Goettel, Jeremy; Kotlarz, Daniel; Illig, David; More

Inflammatory Bowel Diseases . 23():S4, February 2017.

O-014 Bacterial Sensor NOD2 Deletion Causes Th2-Inflammatory Bowel Disease Improvement Without Inducing Acute Metatranscriptomic Dysbiosis in Mice.

Rodriguez-Palacios, Alexander; Corridoni, Daniele; Di Stefano, Gabriella; More

Inflammatory Bowel Diseases . 23():S5, February 2017.


PDF Only


PD-002 Mucosal Healing with Vedolizumab in Ulcerative Colitis and Crohn's Disease: Outcomes from the VICTORY Consortium.

Kochhar, Gursimran; Parikh, Malav; Chaudrey, Khadija; More

Inflammatory Bowel Diseases . 23():S6, February 2017.

PD-003 Female Sexual Function in Inflammatory Bowel Disease: Longitudinal Study Results from the Ocean State Crohn's and Colitis Area Registry.

Shmidt, Eugenia; Suarez-Farinas, Mayte; Mallette, Meaghan; More

Inflammatory Bowel Diseases . 23():S6, February 2017.

PD-005 Male Sexual Function in Inflammatory Bowel Disease: Longitudinal Study Results from the Ocean State Crohn's and Colitis Area Registry.

Shmidt, Eugenia; Suarez-Farinas, Mayte; Mallette, Meaghan; More

Inflammatory Bowel Diseases . 23():S7, February 2017.

PD-009 A Phase 2B, Multicenter, Randomized, Placebo-Controlled Dose-Ranging Trial of Peficitinib, an Oral JAK Inhibitor, in Patients with Moderately-Severely Active UC.

Sands, Bruce; Sandborn, William; Feagan, Brian; More

Inflammatory Bowel Diseases . 23():S8, February 2017.

PD-010 Histological Remission Induced by Ozanimod is Associated with Clinical Remission and Endoscopic Mucosal Healing: Results from the TOUCHSTONE Study.

William, Sandborn; Brian, Feagan; Geert, D. 'Haens; More

Inflammatory Bowel Diseases . 23():S8-S9, February 2017.

PD-011 Efficacy, Safety and Timing of Dose Adjustment of Subcutaneous Ustekinumab Maintenance in Moderate -Severe Crohn's Disease Patients in IM-UNITI.

Bruce, Sands; Christopher, Gasink; Douglas, Jacobstein; More

Inflammatory Bowel Diseases . 23():S9, February 2017.

PD-012 Endoscopic Healing in the Ustekinumab Phase 3 UNITI/IMUNITI Crohn's Disease Program and Relationship of Clinical Outcomes to Baseline Ulceration Status.

William, Sandborn; Christopher, Gasink; Daphne, Chan; More

Inflammatory Bowel Diseases . 23():S9, February 2017.

PD-013 High-Definition White-Light Endoscopy Versus High-Definition Chromoendoscopy in Detection of Dysplasia in Long-Standing Ulcerative Colitis: A Multicenter Prospective...

Jung, Park Soo; Hyun-Soo, Kim; Dong-Hoon, Yang; More

Inflammatory Bowel Diseases . 23():S10, February 2017.


PDF Only


P-040 Assessing Risk Factors Predicting Loss of Response to Vedolizumab in Ulcerative Colitis and Crohn's Disease: Outcomes from the VICTORY Consortium.

Shmidt, Eugenia; Winters, Adam; Katta, Leah; More

Inflammatory Bowel Diseases . 23():S18, February 2017.

P-043 Feasibility of a Multicenter, Collaborative, Longitudinal, Quality Improvement Learning Health System for Adult IBD Care.

Melmed, Gil; McCutcheon Adams, Kelly; Bray, Harry; More

Inflammatory Bowel Diseases . 23():S19, February 2017.

P-049 Validated Prediction Model for Clinical Remission with Vedolizumab in Crohn's Disease: Post Hoc Analysis of GEMINI II Clinical Trial.

Dulai, Parambir; Boland, Brigid; Singh, Siddharth; More

Inflammatory Bowel Diseases . 23():S21, February 2017.

P-052 Project Sonar: Patient Engagement Reduced Relative Risk and Cost of Care in an Attributed Cohort of Patients with Crohn's Disease.

Kosinski, Lawrence; Baum, Charles; Brill, Joel; More

Inflammatory Bowel Diseases . 23():S22, February 2017.

P-056 Development of a Clinical Care Pathway to Identify and Treat Malnutrition in Patients with Inflammatory Bowel Disease.

Hwang, Caroline; Reddy, Swapna; Issokson, Kelly; More

Inflammatory Bowel Diseases . 23():S23, February 2017.

P-061 Impact of Dose Escalation with Anti-TNFs on Healthcare Resource Utilization Among Patients with Crohn's Disease: A Multi-Country Chart Review.

Pérez Gisbert, Javier; Patel, Haridarshan; Nguyen, Geoffrey; More

Inflammatory Bowel Diseases . 23():S25, February 2017.

P-063 A Retrospective United Kingdom Chart Review of Early Vedolizumab Experience: Real-World Treatment, Effectiveness and Safety in Inflammatory Bowel Disease (REVIVE).

Cummings, Fraser; Gaya, Daniel; Irving, Peter; More

Inflammatory Bowel Diseases . 23():S25-S26, February 2017.

P-067 YI Evaluation of Gastrointestinal Patient Reported Outcomes Measurement Information System (GI-PROMIS) Domains in Inflammatory Bowel Diseases Subjects in CCFA Partners.

Kochar, Bharati; Martin, Christopher; Kappelman, Michael; More

Inflammatory Bowel Diseases . 23():S27, February 2017.

P-069 Rates, Trends and Predictors of 30-Day Readmission of Crohn's Disease: A National Perspective.

Pathak, Ambarish; Savani, Chirag; Devani, Kalpit; More

Inflammatory Bowel Diseases . 23():S28, February 2017.

P-074 Increased Fecal Calprotectin and Penetrating Phenotype Are Strong Predictors of Small Intestinal Bacterial Overgrowth in Crohn's Disease Patients.

Ricci, José Eugênio Jr; Chebli, Liliana; Ribeiro, Tarsila; More

Inflammatory Bowel Diseases . 23():S29, February 2017.

P-081 YI Smoking and Inflammatory Bowel Disease: A Comparison Between Chinese and American Populations.

Wang, Peiqi; Hu, Jun; Ghadermarzi, Shadi; More

Inflammatory Bowel Diseases . 23():S31-S32, February 2017.

P-083 Influence of Patient and Hospital Characteristics on Length of Stay and Cost of Care in Crohn's Disease Patients.

Pathak, Ambarish; Savani, Chirag; Shah, Harshil; More

Inflammatory Bowel Diseases . 23():S32, February 2017.

P-084 Rates, Trends and Predictors of 30-Day Readmission of Ulcerative Colitis: A National Perspective.

Savani, Chirag; Devani, Kalpit; Mishra, Tushar; More

Inflammatory Bowel Diseases . 23():S32-S33, February 2017.

P-088 Diabetic Nephropathy and IgA Nephropathy are the Most Prevalent Nephrotic/Nephritic Disease in Inflammatory Bowel Disease.

Sharma, Prabin; Aguilar, Rodrigo; Mordon, Armenia; More

Inflammatory Bowel Diseases . 23():S34, February 2017.

1 2 3 4 Next